These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6395237)

  • 1. Inhibitory effects of PGE1 and E2 on glucose induced insulin release.
    Villar del Fresno A; D'Ocon MP; Ivorra MD; Anselmi E
    Rev Esp Fisiol; 1984 Sep; 40(3):385-7. PubMed ID: 6395237
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostaglandin E1: stimulation of somatostatin and insulin responses to glucose from the isolated perfused rat pancreas.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Ishida H; Imura H
    Prostaglandins Leukot Med; 1982 Jun; 8(6):593-7. PubMed ID: 6125951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of PGE1 on glucose induced insulin release in isolated islets of Langerhans.
    D'Ocon P; del Río H; Villar A
    Rev Esp Fisiol; 1988 Jun; 44(2):151-5. PubMed ID: 3057545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pancreatic secretion in rats treated with intra-aortic prostaglandin E1].
    García-Casarrubios A; Carbonell I; Alonso de Armiño V; Frasquet I
    Rev Esp Fisiol; 1983 Mar; 39(1):77-81. PubMed ID: 6346415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose dependent stimulation by prostaglandin D2 of glucagon and insulin in perfused rat pancreas.
    Matsuyama T; Horie H; Namba M; Nonaka K; Tarui S
    Life Sci; 1983 Feb; 32(9):979-82. PubMed ID: 6338336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
    Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Shimizu T; Hayashi O; Imura H
    Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of PGE2 on alloxan-induced inhibition of insulin release in isolated neonatal rat pancreatic islets].
    Wang JL; Song Y; Zhu WY
    Sheng Li Xue Bao; 1986 Dec; 38(6):643-9. PubMed ID: 3554526
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclic AMP-antagonist, a second messenger for insulin action, inhibits glucose-stimulated insulin secretion in isolated islets of Chinese hamsters.
    Partke HJ; Wasner HK
    Adv Exp Med Biol; 1986; 211():409-12. PubMed ID: 2440248
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets.
    Pace-Asciak CR; Martin JM
    Prostaglandins Leukot Med; 1984 Nov; 16(2):173-80. PubMed ID: 6396652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interference with phospholipase A2 activity reveals mechanistic differences between glucose and glyceraldehyde induced insulin release: implication for coupling of glucose metabolism to phospholipase A2 activity.
    Tadayyon M; Green IC
    Diabete Metab; 1993; 19(1):36-43. PubMed ID: 8504883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of prostaglandin E synthesis augments glucose-induced insulin secretion is cultured pancreas.
    Metz SA; Robertson RP; Fujimoto WY
    Diabetes; 1981 Jul; 30(7):551-7. PubMed ID: 7018961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of prostaglandins H2, D2, I2, and thromboxane on in vitro secretion of glucagon and insulin.
    Pek S; Lands WE; Akpan J; Hurley M
    Adv Prostaglandin Thromboxane Res; 1980; 8():1295-8. PubMed ID: 6990716
    [No Abstract]   [Full Text] [Related]  

  • 13. [Inhibitory effect of PGE1 on the liberation of insulin induced by glibenclamide].
    Villar A; D'Ocón MP; Anselmi E
    Rev Esp Fisiol; 1985 Dec; 41(4):451-5. PubMed ID: 3938043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of insulin secretion in normal and diabetic humans by prostaglandin E and sodium salicylate.
    Robertson RP; Chen M
    Trans Assoc Am Physicians; 1977; 90():353-65. PubMed ID: 347676
    [No Abstract]   [Full Text] [Related]  

  • 15. Opiate-prostaglandin interactions in the regulation of insulin secretion from rat islets of Langerhans in vitro.
    Green IC; Tadayyon M
    Life Sci; 1988; 42(21):2123-30. PubMed ID: 2898715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of insulin secretion by cyclic AMP and prostaglandin E: the effects of theophylline, sodium salicylate and tolbutamide.
    Metz S; Fujimoto W; Robertson RP
    Metabolism; 1982 Oct; 31(10):1014-22. PubMed ID: 6290835
    [No Abstract]   [Full Text] [Related]  

  • 17. [Insulin production of isolated fresh and cryopreserved islands of Langerhans of rats].
    Gerö L; Horányi J; Kiss IB; Keszthelyi LM; Dufek L; Alánt O
    Z Exp Chir Transplant Kunstliche Organe; 1985; 18(4):224-9. PubMed ID: 3901556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of maltose on insulin release by glucose from isolated pancreatic islets.
    Kita S; Gotoh S; Sakaki S; Higashi K; Sakamoto Y
    Med J Osaka Univ; 1979 Sep; 30(1-2):25-30. PubMed ID: 398438
    [No Abstract]   [Full Text] [Related]  

  • 19. Calmodulin dependency of induced glucose responsiveness in neonatal islets.
    Dunlop M; Larkins RG; Court JM
    Horm Metab Res; 1983 Oct; 15(10):514-5. PubMed ID: 6357981
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of cyclooxygenase inhibition on prostaglandin production and insulin and glucagon secretion by isolated rat islets.
    Spangler RS; Pek SB
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 12():291-7. PubMed ID: 6221605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.